Otsuka America Pharmaceutical

Qugen Inc. is a significant player in the Contract Manufacturing Services sector, operating across various North American markets. The company specializes in a diverse array of OTC pharmaceutical products, including soft gels, tablets, capsules, dietary supplements, and bulk drugs. With extensive expertise in this field, Qugen Inc. upholds very high quality standards in its manufacturing processes. Their commitment to excellence ensures that they deliver reliable and effective products to their clients. Generated from the website

Akorn is a vertically integrated pharmaceutical company that focuses on specialty markets that include ophthalmology, anesthesia, antidotes and rheumatology. It is a specialty pharmaceutical company engaged in the development, manufacturing and marketing of branded and multi-source pharmaceutical products. As a specialty pharmaceutical company, Akorn is focused on three major business segments. These three segments are ophthalmology, hospitals and contract manufacturing. With a historical revenue base of more than $50 million, Akorn s eye is on the future. The company serves a wide variety of customers in the health care field. It has contract manufacturing strategic relationships with large pharmaceutical organizations such as Pfizer, Baxter, Novartis and B. Braun. Akorn has a location in Somerset, N.J.

Ortho-McNeil-Janssen Pharmaceuticals offers a range of health care products for the treatment of several infectious diseases, as well as pain management. The company s sister concern Ortho-McNeil, which serves primary care hospitals and other care facilities. Ortho-McNeil s products are available under the DURAGESIC, LEVAQUIN, FLOXIN, NIZORAL and PROPULSID brads. The company provides injections, shampoos, caplets, tablets and capsules. Ortho-McNeil offers the ACIPHEX product, which is used of the treatment of heartburn and other symptoms associated with acid reflux disease. The company additionally provides the DORIBAX product for patients with gram negative infections. Ortho-McNeil undertakes several research and development activities.